Tumor-Secreted microRNAs as Circulating Biomarkers for Lung Cancer Detection and Prognostic Stratification
Cancers · 17.11.2026 · 18 (22) · 3667
DOI: 10.3390/cancers18223667 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 17.11.2026. Verfasst von Pranabananda Dutta und 3 weiteren Autor:innen. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of California San Diego.
Abstract (Originalsprache)
Background
Early lung cancer detection remains challenging. Low-dose CT screening reduces mortality but is limited by false positives and low uptake. Circulating miRNAs are stable blood biomarkers, but reproducibility is poor as most derive from non-tumor tissues. We hypothesized that miRNAs secreted by lung cancer cells would provide more grounded biomarkers.
Methods
Small RNA sequencing was performed on paired intracellular and extracellular RNA from conditioned media of six NSCLC cell lines and non-malignant controls. Differentially expressed miRNAs enriched in cancer-derived fractions were identified. Candidates were validated in serum from NSCLC patients and controls by RT-qPCR and examined in TCGA cohorts. Pathway and survival analyses assessed relevance.
Results
Extracellular miRNA profiles were conserved across NSCLC lines and distinct from intracellular profiles. A core set of 25 miRNAs was enriched in cancer-derived media. Five miRNAs (miR-10b, miR-25, miR-92a, miR-182, miR-375) were elevated in NSCLC serum and robustly expressed in TCGA tumors. Pathway analysis showed enrichment of PI3K–Akt and hypoxia signaling. Elevated miR-10b was associated with poorer survival.
Conclusions
Lung cancer cells secrete a conserved miRNA set detectable in serum and tumors, linked to oncogenic pathways and survival. Cell-based profiling offers a strategy for developing plasma miRNA assays for lung cancer detection.
Förderung
- University of California San Diego
Zitieren
APA
Dutta, P., Zhang, L., Li, J., & Li, W. X. (2026). Tumor-Secreted microRNAs as Circulating Biomarkers for Lung Cancer Detection and Prognostic Stratification. Cancers, 18(22), 3667. https://doi.org/10.3390/cancers18223667
Vancouver
Dutta P, Zhang L, Li J, Li WX. Tumor-Secreted microRNAs as Circulating Biomarkers for Lung Cancer Detection and Prognostic Stratification. Cancers. 2026;18(22):3667. doi:10.3390/cancers18223667
BibTeX
@article{Dutta2026,
author = {Dutta, Pranabananda and Zhang, Lin and Li, Jinghong and Li, Willis X.},
title = {Tumor-Secreted microRNAs as Circulating Biomarkers for Lung Cancer Detection and Prognostic Stratification},
journal = {Cancers},
year = {2026},
volume = {18},
number = {22},
pages = {3667},
doi = {10.3390/cancers18223667}
}
EUVIMED